thymidine 5'-triphosphate has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, EY; Hahn, TM; Hertel, LW; Lawrence, TS; Shewach, DS | 1 |
| Berkenblit, R; Damle, S; Haynes, H; Kaleya, R; Ladner, RD; Murgo, A; Schechner, R; Wadler, S | 1 |
1 trial(s) available for thymidine 5'-triphosphate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Phase II/pharmacodynamic trial of dose-intensive, weekly parenteral hydroxyurea and fluorouracil administered with interferon alfa-2a in patients with refractory malignancies of the gastrointestinal tract.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxyuracil Nucleotides; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Hydroxyurea; Interferon alpha-2; Interferon-alpha; Leukocytes, Mononuclear; Male; Middle Aged; Pancreatic Neoplasms; Prospective Studies; Recombinant Proteins; Stomach Neoplasms; Thymine Nucleotides; Treatment Outcome | 1999 |
1 other study(ies) available for thymidine 5'-triphosphate and Pancreatic Neoplasms
| Article | Year |
|---|---|
Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
Topics: Adenosine Triphosphate; Cell Cycle; Cell Survival; Cytidine Triphosphate; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Guanosine Triphosphate; Humans; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Thymine Nucleotides; Tumor Cells, Cultured | 1996 |